Abbott Bids To Toss New Government Claims

Law360, New York (July 18, 2007, 12:00 AM EDT) -- Abbott Laboratories, one of a slew of pharmaceutical makers involved in a massive antitrust class action alleging the companies defrauded consumers by artificially inflating the prices for various prescription drugs, has moved to dismiss fresh claims brought by government authorities.

The pharmaceutical giant said in court documents filed Tuesday that the United States' first amended complaint against Abbott – which was lodged June 4 – should be dismissed because its claims are barred by the statute of limitations.

Specifically, Abbott took issue with the government's claims...
To view the full article, register now.